Texas Biotechnology announces new preclinical, clinical data and future plans for sitaxsentan Oct. 19, 1999
UL-TG-307: effects on insulin sensitivity, secretion and metabolic effects in type II diabetics Oct. 19, 1999
Effects of darglitazone on body weight, food intake and MC4 receptors in obese Zucker rats Oct. 19, 1999
Highlights from EASD annual meeting: DPP-IV inhibitor shows promise in type II diabetes Oct. 18, 1999
RSS